NEO - NeoGenomics, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Fort Myers,
United States
Type: Equity
NEO price evolution
NEO
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $355.08 | $331.91 | $342.49 | |
| Short term investments | $32.77 | $52.92 | $72.72 | |
| Net receivables | $151.43 | $146.58 | $140.28 | $131.23 |
| Inventory | $24.46 | $23.21 | $20.32 | $24.16 |
| Total current assets | $590.24 | $584.2 | $573.9 | $596.81 |
| Long term investments | ||||
| Property, plant & equipment | $174.48 | $175.83 | $174.44 | $183.78 |
| Goodwill & intangible assets | $879.17 | $887.53 | $895.89 | |
| Total noncurrent assets | $1059.07 | $1066.44 | $1084.42 | |
| Total investments | $32.77 | $52.92 | $72.72 | |
| Total assets | $1641.11 | $1643.28 | $1640.34 | $1681.23 |
| Current liabilities | ||||
| Accounts payable | $16.51 | $17.19 | $18.34 | $20.33 |
| Deferred revenue | $0.97 | $1.14 | $2.13 | |
| Short long term debt | $203.65 | $4.49 | $5.61 | |
| Total current liabilities | $296.41 | $289.96 | $76.71 | $96.3 |
| Long term debt | $339.96 | $402.87 | $603.7 | $606.07 |
| Total noncurrent liabilities | $437.43 | $640.22 | $643.39 | |
| Total debt | $606.52 | $608.18 | $611.68 | |
| Total liabilities | $732.9 | $727.39 | $716.93 | $739.69 |
| Shareholders' equity | ||||
| Retained earnings | -$310.46 | -$292.76 | -$274.12 | -$247.06 |
| Other shareholder equity | -$0.64 | -$1.02 | -$1.33 | -$1.67 |
| Total shareholder equity | $915.88 | $923.41 | $941.54 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $342.49 | $263.18 | $316.83 | $228.71 |
| Short term investments | $72.72 | $174.81 | $198.56 | $67.55 |
| Net receivables | $131.23 | $121.61 | $112.13 | $106.84 |
| Inventory | $24.16 | $24.28 | $23.39 | $29.53 |
| Total current assets | $596.81 | $605.29 | $681.51 | $448.73 |
| Long term investments | $51.47 | |||
| Property, plant & equipment | $183.78 | $198.61 | $211.66 | $131.66 |
| Goodwill & intangible assets | $895.89 | $931.03 | $969.44 | $331.74 |
| Total noncurrent assets | $1084.42 | $1134.74 | $1188.27 | $539.6 |
| Total investments | $72.72 | $174.81 | $198.56 | $119.02 |
| Total assets | $1681.23 | $1740.03 | $1869.78 | $988.33 |
| Current liabilities | ||||
| Accounts payable | $20.33 | $20.51 | $17.92 | $24.96 |
| Deferred revenue | $2.13 | |||
| Short long term debt | $5.61 | $6.65 | $8.02 | $7.81 |
| Total current liabilities | $96.3 | $89.93 | $87.23 | $73.18 |
| Long term debt | $606.07 | $535.32 | $604.84 | $211.38 |
| Total noncurrent liabilities | $643.39 | $652.08 | $674.27 | $220.85 |
| Total debt | $611.68 | $610.93 | $612.86 | $219.19 |
| Total liabilities | $739.69 | $742.01 | $761.5 | $294.04 |
| Shareholders' equity | ||||
| Retained earnings | -$247.06 | -$159.09 | -$14.84 | -$7.18 |
| Other shareholder equity | -$1.67 | -$3.9 | -$0.64 | $0.01 |
| Total shareholder equity | $941.54 | $998.02 | $1108.28 | $694.29 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $167.82 | $164.5 | $156.24 | $155.55 |
| Cost of revenue | $92.01 | $90.77 | $87.96 | |
| Gross Profit | $74.88 | $72.49 | $65.47 | $67.59 |
| Operating activities | ||||
| Research & development | $7.89 | $7.62 | $7.13 | |
| Selling, general & administrative | $85 | $86.02 | $77.83 | |
| Total operating expenses | $95.07 | $94.44 | $96.04 | $86.16 |
| Operating income | -$21.94 | -$30.57 | -$18.57 | |
| Income from continuing operations | ||||
| EBIT | -$17.35 | -$26 | -$1.55 | |
| Income tax expense | -$0.15 | -$0.38 | -$0.62 | -$0.96 |
| Interest expense | $3.03 | $1.67 | $1.69 | $13.74 |
| Net income | ||||
| Net income | -$17.7 | -$18.64 | -$27.06 | -$14.33 |
| Income (for common shares) | -$18.64 | -$27.06 | -$14.33 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $591.64 | $509.73 | $484.33 | $444.45 |
| Cost of revenue | $347.04 | $321.83 | $297.27 | $258.56 |
| Gross Profit | $244.6 | $187.9 | $187.06 | $185.89 |
| Operating activities | ||||
| Research & development | $27.31 | $30.33 | $21.87 | $8.23 |
| Selling, general & administrative | $313.94 | $310.68 | $283.94 | $191.66 |
| Total operating expenses | $352.34 | $345.52 | $305.81 | $199.88 |
| Operating income | -$107.74 | -$157.62 | -$118.75 | -$13.99 |
| Income from continuing operations | ||||
| EBIT | -$90.19 | -$157.84 | -$9.99 | -$7.04 |
| Income tax expense | -$9.13 | -$15.09 | -$6.73 | -$18.23 |
| Interest expense | $6.91 | $1.51 | $5.08 | $7.02 |
| Net income | ||||
| Net income | -$87.97 | -$144.25 | -$8.35 | $4.17 |
| Income (for common shares) | -$87.97 | -$144.25 | -$8.35 | $4.17 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$18.64 | -$27.06 | -$14.33 | |
| Operating activities | ||||
| Depreciation | $20.5 | $20.67 | $20.74 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $8.84 | $7.77 | $6.99 | |
| Total cash flows from operations | $13.89 | -$25.91 | $17.78 | |
| Investing activities | ||||
| Capital expenditures | -$13.08 | -$5.58 | -$7.06 | |
| Investments | $20.39 | $20.11 | $24.25 | |
| Total cash flows from investing | $18.32 | $7.31 | $14.53 | $17.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.97 | $0.82 | $1.27 | |
| Net borrowings | -$0 | |||
| Total cash flows from financing | $3.96 | $1.97 | $0.82 | $1.27 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $19.5 | $23.17 | -$10.57 | $36.25 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$87.97 | -$144.25 | -$8.35 | $4.17 |
| Operating activities | ||||
| Depreciation | $81.82 | $79.2 | $62.07 | $41.89 |
| Business acquisitions & disposals | -$434.4 | -$62.6 | ||
| Stock-based compensation | $24.63 | $24.67 | $22.46 | $10.21 |
| Total cash flows from operations | -$1.95 | -$65.99 | -$26.72 | $1.46 |
| Investing activities | ||||
| Capital expenditures | -$28.75 | -$30.89 | -$64.14 | -$29.1 |
| Investments | $105.46 | $19.31 | -$133.82 | -$67.75 |
| Total cash flows from investing | $76.71 | $0.52 | -$632.37 | -$159.44 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.62 | $12.59 | $423.21 | $147.6 |
| Net borrowings | -$0.07 | -$0.76 | $331.36 | $91.31 |
| Total cash flows from financing | $4.55 | $11.83 | $725.28 | $235.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $79.31 | -$53.65 | $66.19 | $77.62 |
News
Fundamentals
| Market cap | $1.42B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 128.06M |
| Revenue | $644.12M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$77.73M |
| Revenue Q/Q | 10.44% |
| Revenue Y/Y | 12.06% |
| P/E ratio | -18.29 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.21 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.61 |
|---|---|
| ROA | -4.71% |
| ROE | N/A |
| Debt/Equity | 0.79 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.99 |
| Quick ratio | 1.91 |